The evidences questioning the anti-obesity effects of FGF21 in adolescent with obesity remains scarce, while an association between increased circulating FGF21 and metabolic disorders has been reported in adults. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.